Evidence map›Paper›PMID 21520066›Full record

ArticleJournal of cellular physiology2011

Osteopontin controls endothelial cell migration in vitro and in excised human valvular tissue from patients with calcific aortic stenosis and controls.

Paolo Poggio, Juan B Grau, Benjamin C Field, Rachana Sainger, William F Seefried, Flavio Rizzolio, Giovanni Ferrari

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cellular physiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Osteopontin in Atrial Fibrillation and Atrial Remodeling.Journal of the American Heart Association · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Determination of osteopontin in monitoring retinal damage in metabolic syndrome.International journal of experimental pathology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Osteopontin accumulates in basal deposits of human eyes with age-related macular degeneration and may serve as a biomarker of aging.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2022
    Article
  12. Review
  13. Article
  14. Osteopontin in Bone Metabolism and Bone Diseases.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Review
  15. The endothelial tip-stalk cell selection and shuffling during angiogenesis.Journal of cell communication and signaling · 2019
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Atherosclerotic Calcification: Wnt Is the Hint.Journal of the American Heart Association · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Paolo PoggioDivision of Cardiovascular Surgery, Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19036, USA.
Juan B Grau
Benjamin C Field
Rachana Sainger
William F Seefried
Flavio Rizzolio
Giovanni Ferrari
University of Pennsylvania · USTemple University · US

Funding

Osteopontin: a Novel Biomarker for Calcific Aortic Valve DiseasesRC1HL100035 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI FERRARI, GIOVANNI · 2009 to 2010
$999k
NHLBI NIH HHS RC1 HL100035NHLBI NIH HHS RC1HL100035
6 · The paper itself

Abstract

Calcific aortic stenosis (CAS) is a pathological condition of the aortic valve characterized by dystrophic calcification of the valve leaflets. Despite the high prevalence and mortality associated with CAS, little is known about its pathogenetic mechanisms. Characterized by progressive dystrophic calcification of the valve leaflets, the early stages of aortic valve degeneration are similar to the active inflammatory process of atherosclerosis including endothelial disruption, inflammatory cell infiltration, lipid deposition, neo-vascularization and calcification. In the vascular system, the endothelium is an important regulator of physiological and pathological conditions; however, the contribution of endothelial dysfunction to valvular degeneration at the cellular and molecular level has received little attention. Endothelial cell (EC) activation and neo-vascularization of the cusps characterizes all stages of aortic valvular degeneration from aortic sclerosis to aortic stenosis. Here we reported the role of osteopontin (OPN) in the regulation of EC activation in vitro and in excised tissue from CAS patients and controls. OPN is an important pro-angiogenic factor in several pathologies. High levels of OPN have been demonstrated in both tissue and plasma of patients with aortic valve sclerosis and stenosis. The characterization of valvular ECs as a cellular target for OPN will help us uncover the pathogenesis of aortic valve degeneration and stenosis, opening new perspectives for the prevention and therapy of this prevalent disease.

Indexed as

AdultAgedAged, 80 and overAortic Valve StenosisCalcinosisCell MovementCells, CulturedEndothelial CellsFemaleHumansMaleMiddle AgedNeovascularization, PathologicOsteopontinOsteopontin

Identifiers

PMID21520066
PMCPMC3523737
OpenAlexW2062221323

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.